BIOL Biolase
- 0.069
- -0.008-10.78%
Biolase News
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersNexalin Technology (NASDAQ:NXL) stock increased by 48.1% to $1.54 during Wednesday's after-market session. The company's market cap stands at $11.4 million. Tempest Therapeutics (NASDAQ:TPST) s
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 60.2% to $0.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.2 million. As per the press release,
Express News | Biolase Shares Are Trading Lower After the Company Announced That It Will Delist From the Nasdaq
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersNexalin Technology (NASDAQ:NXL) shares rose 55.8% to $1.62 during Tuesday's after-market session. The market value of their outstanding shares is at $12.0 million. Dynatronics (NASDAQ:DYNT) sto
Express News | BIOLASE To Delist From Nasdaq
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 63.8% to $0.28 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. As per the news, the Q4 earnings rep
Express News | BIOLASE Inc: On June 17, Nasdaq Notified Co That It Determined to Delist Co's Common Stock
BIOLASE Announces Delisting From Nasdaq
LAKE FOREST, CA / ACCESSWIRE / June 18, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a global leader in dental lasers, today announced that the Company received a notice from Nasdaq that it has determined to d
Global Robotic Dentistry Market Report 2024-2029, Featuring Key Players Dentsply Sirona, Biolase, 3Shape, Straumann Group, Navigate Surgical Technologies, X-Nav Technologies and Image Navigation
Biolase Offering Units That Contain Stock and Warrants
Biolase Offering Units That Contain Stock and Warrants
Biolase Buy Rating Affirmed Amid Growth Opportunities and Proactive Cost Management
Express News | BIOLASE Inc : Ascendiant Capital Markets Cuts Target Price to $3.5 From $4
Express News | BIOLASE -on May 14, Received Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard From Nasdaq
Maxim Group Downgrades Biolase (BIOL) to a Hold
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersDelcath Systems (NASDAQ:DCTH) stock rose 33.2% to $7.19 during Tuesday's regular session. The company's market cap stands at $199.8 million. As per the news, the Q1 earnings report came out tod
Biolase Price Target Maintained With a $0.40/Share by Benchmark
Biolase Price Target Maintained With a $0.40/Share by Benchmark
Express News | Benchmark Reiterates Speculative Buy on Biolase, Maintains $0.4 Price Target
Biolase Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 159.91% Benchmark → $0.4 Reiterates Speculative Buy → Speculative Buy 04/01/2024 2499.09% Ascen
Wall Street Set to Open Flat Tuesday as Key Inflation Gauge Rises More Than Expected
US stocks look set to open flat in Tuesday's session as a main indicator of inflation came in higher than expected earlier in the morning. The Dow Jones Industrial Average futures were up 0.06%, S&P 5
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Alcon Inc. (NYSE:ALC) rose sharply in today's pre-market trading following better-than-expected first-quarter earnings.Alcon posted adjusted earnings of 78 cents per share, beating market ex
Analysis
Price Target
No Data
